logo
  1. Home
  2. Stocks
  3. Thyrocare Technologies

Thyrocare Technologies Share Price

Small Cap | Pharmaceuticals and health care | NSE: THYROCARE | BSE: 539871

₹692.40 image-28.40 (-3.94 %)

Last Updated: 04 Apr 2025 03:46 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 724.00

High (₹) 724.00

Low (₹) 685.00

Prev. Close (₹) 720.80

Volume 29,205

VWAP (₹) 691.02

ROCE (%) 18.03

Industry P/E 96.77

TTM P/E 41.84

P/B Ratio 6.95

Market Cap (₹) Cr.3,669.27

Dividend Yield (%)2.60

EPS (₹) 13.40

ROE13.45%

Sales Growth (%) 8.58

Profit Growth (%)9.37

Day Range

724.00724.00

L
H

52 Week Range

570.751,053.05

L
H

Historical Returns

Returns (6M)

-11.98 %

Returns (1Y)

8.63 %

Returns (3Y)

-17.64 %

Returns (5Y)

31.51 %

Returns (6M)

-11.98 %

Returns (1Y)

8.63 %

Returns (3Y)

-17.64 %

Returns (5Y)

31.51 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (10.38%) TTM EPS Growth
  • Company with Low Debt
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company with 10.38% positive TTM EPS growth

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 34.26

MFI 18.22

ATR 31.90

Commodity Channel Index -103.36

ROC125 -21.50

ROC21 -11.53

Williams %R -89.53

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current721.34755.12778.29698.17664.39641.22607.44
Week Ago737.36748.98762.66723.68712.06698.38686.76
Month Ago793.05823.80842.85774.00743.25724.20693.45

EMA & SMA
info_icon

692.40

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 719.24

9 Day 716.03

10 Day 717.26

12 Day 725.92

14 Day 732.94

20 Day 750.13

26 Day 756.80

50 Day 832.81

100 Day 881.75

200 Day 808.54

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GRAVITON RESEARCH CAPITAL LLPbulkSell24 Jul, 2024₹719.482,80,202NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy24 Jul, 2024₹719.082,79,124NSE
SOCIETE GENERALEbulkBuy21 Jun, 2023₹527.932,96,123NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell22 Dec, 2022₹702.212,82,766NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell22 Dec, 2022₹696.074,26,975NSE
BAJAJ ALLIANZ LIFE INSURANCE COMPANY LTDbulkSell22 Dec, 2022₹659.692,75,000NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy22 Dec, 2022₹701.742,82,766NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy22 Dec, 2022₹694.574,26,975NSE
FUNDSMITH EMERGING EQUITIES TRUST PLCbulkSell29 Aug, 2022₹614.792,68,707NSE
XTX MARKETS LLPbulkSell28 Jun, 2021₹1,340.362,69,601NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
31 Jan, 2025Priyanka Jagnani JainAcquisition₹776.43245NSE
31 Jan, 2025Priyanka Jagnani JainAcquisition₹765.87555NSE
31 Jan, 2025Priyanka Jagnani JainAcquisition₹761.00200NSE
05 Nov, 2024Rahul GuhaAcquisition₹925.0021NSE
05 Nov, 2024Rahul GuhaAcquisition₹965.201,111NSE
18 Jun, 2024DOCON TECHNOLOGIES PRIVATE LIMITEDPledge₹NSE
12 Jun, 2024Alok Kumar Jagnani RevisedDisposal₹626.00175NSE
12 Jun, 2024Alok Kumar Jagnani RevisedAcquisition₹573.00175NSE
11 Jun, 2024Alok Kumar JagnaniDisposal₹593.92500NSE
16 Aug, 2023Alok Kumar JagnaniAcquisition₹575.37500NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
14 May, 2024Rs.18.0000 per share(180%)Final Dividend16 Aug, 202416 Aug, 2024
10 Apr, 2023Rs.18.0000 per share(180%)Interim Dividend20 Apr, 202320 Apr, 2023
02 May, 2022Rs.15.0000 per share(150%)Interim Dividend11 May, 202212 May, 2022

Announcements

DateSourceDetail
27 Mar, 2025NSE IndiaThyrocare Technologies Limited has informed the Exchange about Closure of Trading Window
27 Mar, 2025NSE IndiaThyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
13 Mar, 2025NSE IndiaThe Exchange had sought clarification from Thyrocare Technologies Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is enclosed.
04 Mar, 2025NSE IndiaThyrocare Technologies Limited has informed the Exchange regarding Acquisition
03 Mar, 2025BSE IndiaPlease find attached herewith Disclosure under Regulation 30 for Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited - Joint Venture.
03 Mar, 2025NSE IndiaThyrocare Technologies Limited has informed the Exchange about Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited - Joint Venture.
19 Feb, 2025NSE IndiaThe Exchange has sought clarification from Thyrocare Technologies Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is awaited.
03 Feb, 2025NSE IndiaUpdated Limited Review report on the Consolidated Financial results for the quarter and nine months ended December 31, 2024.
03 Feb, 2025NSE IndiaThyrocare Technologies Limited has informed the Exchange regarding ''Updated Limited Review report on the Consolidated Financial results for the quarter and nine months ended December 31, 2024''.
03 Feb, 2025BSE IndiaThe Company has submitted the financial results along with Limited review report for quarter and nine months ended December 31, 2024. It is hereby submitted that due to an inadvertent error during the scanning process, a page containing Points No 4 to 6 of the Limited review report was inadvertently omitted. The corrected Limited Review report is attached herewith. There are no other changes to earlier intimation made on January 23, 2025.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--17 Jan, 202523 Jan, 2025
Quarterly Results--17 Oct, 202423 Oct, 2024
Quarterly Results--19 Jul, 202423 Jul, 2024
Audited Results & Final Dividend--08 May, 202414 May, 2024
Quarterly Results--25 Jan, 202401 Feb, 2024
Quarterly Results--25 Oct, 202331 Oct, 2023
Quarterly Results--27 Jul, 202301 Aug, 2023
Audited Results--16 May, 202323 May, 2023
Interim Dividend--04 Apr, 202307 Apr, 2023
Quarterly Results--18 Jan, 202303 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group71.11%71.11%71.14%71.18%66.14%
Foreign Institutions +1.93%3.35%10.13%12.02%20.78%
Domestic Institutions +14.79%13.89%8.68%6.71%7.42%
Government0%0%0%0%0%
Public12.17%11.65%10.05%10.09%5.66%
Others0%0%0%0%0%

About Thyrocare Technologies

Thyrocare Technologies is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882. Currently Company is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 524.02 Cr. and Equity Capital is Rs. 52.95 Cr. for the Year ended 31/03/2024.

Parent Organisation

Not Applicable

Founded

2000

Managing Director

Mr. Rahul Guha

NSE Symbol

THYROCARE

Thyrocare Technologies Management

NameDesignation
Mr. Rahul GuhaManaging Director & CEO
Mr. Dharmil ShethNon Executive Director
Mr. Hardik DedhiaNon Executive Director
Mr. Dhaval ShahNon Executive Director
Mr. Gopalkrishna Shivram HegdeIndependent Director
Dr. Indumati GopinathanIndependent Director
Dr. Neetin S DesaiIndependent Director
Dr. Prapti GiladaIndependent Director
Dr. Harshil VoraIndependent Director
Mr. Nishant A ShahIndependent Director
Mr. Anandh SundarIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Max Healthcare Institute₹1,10,595.74₹1,137.65 image
₹1,121.30(1.46%)		₹743.000 - ₹1,227.500
Apollo Hospitals Enterprise₹96,544.93₹6,714.55 image
₹6,671.35(0.65%)		₹5,690.800 - ₹7,545.100
Fortis Healthcare₹49,030.76₹649.45 image
₹659.70(-1.55%)		₹406.350 - ₹744.000
Narayana Hrudayalaya₹34,280.50₹1,677.45 image
₹1,663.45(0.84%)		₹1,087.800 - ₹1,725.000
Global Health₹33,149.05₹1,234.20 image
₹1,239.55(-0.43%)		₹936.050 - ₹1,510.100

FAQs on Thyrocare Technologies

What is the share price of Thyrocare Technologies?

The share price of Thyrocare Technologies on 04 Apr, 2025 is ₹ 692.40.

What is 52W high and 52W low share price of Thyrocare Technologies?

The highest and lowest 52W share prices of Thyrocare Technologies are ₹ 1053.050 and ₹ 570.750

What is the market cap of Thyrocare Technologies?

The market capitalization of Thyrocare Technologies as of 04 Apr, 2025 is ₹ 3,669.27 Crores

What is the P/E ratio of Thyrocare Technologies?

The current P/E ratio of Thyrocare Technologies as of 04 Apr, 2025 is 96.77

What is the PB ratio of Thyrocare Technologies?

The PB ratio of Thyrocare Technologies as of 04 Apr, 2025 is 6.95

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited